Hanson Wade

With just under 3 months to go until the 2nd IMPACCT Real World Evidence Summit returns to Amsterdam, we’re excited to announce the Media Partnership with Labiotech. Join us alongside: ⭐ Alfasigma, Lundbeck, Takeda, Novartis, Pfizer, Galderma, Pharvaris, AstraZeneca, Eli Lilly, Alexion Pharmaceuticals, Astellas Pharma, Sanofi, Amgen, Menarini Silicon Biosystems (and more)... You'll be rubbing shoulders with the Leaders, Directors, Managers, and Specialists in the space who are ready and willing to discuss plans, data sharing optimization, data quality improvements, exchange insights and collaborate on future opportunities. Read more about our collaboration with Labiotech: https://ter.li/ee5cww #rweevent #realworldevidenceeurope #rweeu #rweeuevent #rweconference #realworldevdience

We are pleased to announce our newest media partnership with Pharma Now - Empowering Pharma Leadership 🤝 Pharma Now is a global publication house and next-generation media company designed to empower pharma leadership. As a trusted platform, we bridge industry, innovation, and influence, delivering insightful content, strategic engagement, and impactful storytelling. From cutting-edge research to industry-shaping discussions, we connect the brightest minds, enabling brands to thrive and leaders to drive the future of Pharma. Join us this June. Find out more here ➡️ https://ter.li/833zal

🚀 𝗧𝗼𝗽 𝗥𝗲𝗮𝘀𝗼𝗻𝘀 𝘁𝗼 𝗔𝘁𝘁𝗲𝗻𝗱 𝘁𝗵𝗲 𝟱𝘁𝗵 𝗜𝗻𝗻𝗲𝗿 𝗘𝗮𝗿 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! Join us in Boston this July, as we bring together the brightest minds in inner ear drug development to tackle the biggest challenges and unlock new opportunities. Here’s why you can’t afford to miss it: 🎯 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗲 𝗜𝗻𝗻𝗲𝗿 𝗘𝗮𝗿 𝗗𝗿𝘂𝗴 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 Join our expert-led workshops on innovative approaches to drug delivery and preclinical models for inner ear therapeutics to master cutting-edge drug delivery strategies and accelerate breakthrough preclinical treatments in the inner ear space. 💰 𝗦𝗲𝗰𝘂𝗿𝗲 𝗚𝗮𝗺𝗲-𝗖𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 Gain insider knowledge at our exclusive Investor Panel Discussion from top VCs at Atlas Ventures and Panacea Venture, alongside pharma leaders from Biogen, on how to attract investors and put your best foot forward for funding success. 🏆 𝗕𝘂𝗶𝗹𝗱 𝗮 𝗪𝗶𝗻𝗻𝗶𝗻𝗴 𝗜𝗻𝗻𝗲𝗿 𝗘𝗮𝗿 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 From structuring a top-tier preclinical program with Regeneron to defining clear clinical endpoints with Colleen Le Prell, learn how to design a program that succeeds from start to finish. Want to learn more? Download the Full Event Guide now 🔗 https://ter.li/6kicwp Our expert speaker line-up: Benjamin Chen, Partner, Panacea Venture Benson Jung, Director or Research & Development, Spiral Therapeutics Brandon Cox, Professor, Department of Pharmacology Southern Illinois, Southern Illinois University School of Medicine Christopher R. Cederroth, Principal Scientist, Hospital of the university of Tübingen Colleen Le Prell, Professor & Department Chair, University of Texas at Dallas Dan Giles, PhD, Business Development Manager, Lineage Cell Therapeutics Devin McDougald, Ph.D., Principal Scientist & Group Lead, Gene Therapy Accelerator Unit, Biogen Erin Robertson PhD, AuD, Senior Manager - Digital Biomakers Regeneron Jian Zuo, CEO & Co-Founder Ting Therapeutics Jianxin Bao, Co-Founder & CEO, Gateway Biotechnology Inc. Jonas Dyhrfjeld-Johnsen, PhD, Chief Development Officer & Managing Director Acousia Therapeutics GmbH Jonathan Kil, Chief Executive & Medical Officer, Sound Pharmaceuticals, Inc. Masato Fujioka MD, PhD, Professor and Chair, Department of Molecular Genetics, Kitasato Academic Research Organization, The Kitasato Institute Maurizio Fazio, Principal, Atlas Venture Meghan Drummond, Director of Auditory Sciences, Regeneron Simon Chandler, CEO, Rinri Therapeutics #InnerEarSummit #Biotech #DrugDelivery

The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe will be taking place in FIVE DAYS!   As our audience gear up to improve patient selection and monitoring, they need support with diagnostic testing, CDx manufacturing, regulatory filing and specialised CROs. We have 𝟮𝟳 𝗲𝘅𝗽𝗲𝗿𝘁 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 this year to fulfil that need. Find out more by downloading our free event guide: https://ter.li/0luy3n   Europe's leading providers will be at the summit next week to cater for the rapidly expanding precision medicine market, will you be there to meet them?   Secure your FREE* pass and join us next week, for three jam-packed days of industry networking, knowledge sharing, and learning opportunities.   Grab your ticket here: https://ter.li/0luy3o

🌍ESG leaders are uniting at the ESG in Life Sciences Summit Europe in June 2025!🌍 Our expert ESG voices are uniting from leading companies including Novartis, Bayer, Alnylam Pharmaceuticals, Bristol Myers Squibb, Tecan, Philips, Thermo Fisher Scientific, Arjo, Ipsen, ERGOMED and many more to explore how businesses must move beyond compliance to unlock the true power of ESG... If you need a closer look at our expert speakers session details, download your copy here: https://ter.li/znxx4a This Summit presents an unmatched opportunity to embrace voluntary ESG reporting - not as a burden, but as a strategic advantage. Gain your strategic advantage and €700 discount here: https://ter.li/526eoy P.S. Your discount runs out at midnight on Friday, April 4th so secure your spot ASAP!⏳ #ESG #Sustainability #ESGReporting #CSRD #Environmentalsocialgovernance

Clinical trials are expensive – but streamlined vendor management can save you millions… With a $700 limited time discount, cut costs, reduce delays and improve trial outcomes at the BRAND-NEW Vendor Management & Outsourcing for Clinical Trials Summit in Boston this June. Join us to: ✅ Master vendor communication to prevent costly setbacks ✅ Maximize vendor output with clear KPIs and aligned expectations ✅ Leverage AI for smarter oversight and improved efficiency BONUS: This week only, save $700 with our limited-time early bird discount! Secure your spot now and take the first step toward faster, more cost effective clinical trials. More information is available in the event guide here: https://ter.li/qikz04 Or confirm your place today, with a $700 discount here: https://ter.li/x0bqsx

€700 Discount + Safe, Efficacious Personalized or Off-The-Shelf Therapeutic Options to Patients? If you're working on personalized or off-the-shelf neoantigen-based therapies, this is your chance to save big while gaining the latest insights from industry leaders. Three reasons your team needs to be in the room: 1️⃣ Latest Clinical Breakthroughs – Insights from Nouscom, BioNTech, Evaxion, and Transgene 2️⃣ Optimized Combination Strategies – Unlock the full therapeutic potential of neoantigen therapies 3️⃣ Streamlined Development – Maximize time & cost-effectiveness for faster clinical translation ⏳ Limited-Time €700 Discount – Expiring Friday! ⏳ Find the full agenda details in the event guide here: https://ter.li/q3cy2s Or access the discounted rate (€700) here: https://ter.li/y053jb

Want to know which companies have signed up to attend 5th Medical Device Software Development Summit? Join medical device giants like Novo Nordisk, Merck Group, Roche, Biogen, Johnson & Johnson, Genentech, AbbVie, and many more for 3 days of exclusive content exploring actionable strategies, share best practices, and collaborate on solutions for ensuring the continuous compliance and security of cutting-edge software in a rapidly evolving market. Find out more about the event here >> https://ter.li/8tjsbf Register here and join your peers >> https://ter.li/tw5rbc #MedicalDevice #SoftwareDevelopment #AI #Conference #Networking

€𝟯𝟲𝟳 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁 𝗼𝗳𝗳 your 6th Dermatology Drug Development Summit Europe ticket - 𝙩𝙝𝙞𝙨 𝙬𝙚𝙚𝙠 𝙤𝙣𝙡𝙮! Why should you book on? ✅Develop Competitive Indication Expansion Strategies ✅Explore Late-Breaking Treatment Data ✅Rethink Clinical Endpoints to align with global regulatory authorities ✅Accelerate Collaboration Opportunities Book your place today & save: 𝗵𝘁𝘁𝗽𝘀://𝘁𝗲𝗿.𝗹𝗶/𝘇𝟮𝗹𝟳𝘂𝘇 Why come alone when you can expand your network together? Book on with your colleagues and save up to an extra 20% more off your discounted ticket - 𝗵𝘁𝘁𝗽𝘀://𝘁𝗲𝗿.𝗹𝗶/𝘇𝟮𝗹𝟳𝘂𝘇 #DDDS #DermatologySummit #PharmaLeaders #Networking #Biotech

Our Top Speakers Revealed… Get ready to hear from the brightest minds at the 4th Liquid Biopsy for Precision Oncology East Coast! This is your chance to gain cutting-edge insights from leading pharma, innovative biotech, and leading experts & KOLs the industry has to offer… Brian Dougherty, Executive Director - Global Genomics & Translational Medicine Oncology, AstraZeneca Carolina Reduzzi, Associate Professor & Director of Liquid Biopsies, Weill Cornell Medicine David W., Chief Business Officer, Geneos Therapeutics Emily Chang, Executive Director – Oncology Global Development, Amgen Qing Li, MD. PhD, Director, Pathology, Clinical Development, Oncology, Moderna John Boyce, President & CEO, BrickBio, Inc. At the go-to East Coast event for liquid biopsies, this is your chance to take home actionable insights to ensure you are maximizing the value of liquid biopsies in your therapeutic development strategies. 💡What’s more is that this event is *FREE to attend for drug developers and researchers. If you are interested, register your ticket today (it only takes 2 minutes): https://ter.li/fz74jo Or learn more in the official brochure here: https://ter.li/sp4a93 #LiquidBiopsy #PrecisionOncology #CancerDiagnostics #OncologyInnovation